arabinofuranosyluracil has been researched along with fialuridine in 139 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (9.35) | 18.7374 |
1990's | 61 (43.88) | 18.2507 |
2000's | 45 (32.37) | 29.6817 |
2010's | 18 (12.95) | 24.3611 |
2020's | 2 (1.44) | 2.80 |
Authors | Studies |
---|---|
Drew, WL; King, D; Miner, R | 1 |
King, DH | 1 |
Balasubramaniam, NK; Gentry, GA; Veerisetty, V | 1 |
Arias, C; Borrelli, E; Evans, RM; Heyman, RA; Sawchenko, PE | 1 |
Borrelli, E; Evans, RM; Heyman, R; Hsi, M | 1 |
Coen, DM; Fleming, HE; Leslie, LK; Retondo, MJ | 1 |
Rollinson, EA | 1 |
Bentele, B; Betz, JL; Mitchell, DH; Pizer, LI | 1 |
Gill, MJ; Knaus, EE; Misra, HK; Samuel, J; Tovell, DR; Tyrrell, DL; Wiebe, LI; Yacyshyn, HP | 1 |
Sougawa, M; Tanaka, Y; Yoshii, G | 1 |
De Clercq, E; Groen, J; Osterhaus, AD | 1 |
Cantrell, C; Gerone, PJ; Soike, KF | 1 |
Chen, MS; Oshana, SC; Van Nostrand, M | 1 |
Chou, TC; Fanucchi, MP; Fox, JJ; Watanabe, KA | 1 |
Friedman-Kien, AE; Klein, RJ | 1 |
Hsiung, GD; Mayo, DR | 1 |
Colacino, JM; Staschke, KA | 1 |
Conjeevaram, H; Di Bisceglie, AM; Fried, MW; Kleiner, D; Luciano, C; McKenzie, R; Park, Y; Sallie, R; Savarese, B; Tsokos, M | 1 |
Swartz, MN | 1 |
Dalakas, MC; Lewis, W | 1 |
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW | 2 |
Marwick, C | 2 |
Collins, JM; Katki, AG; Klecker, RW | 1 |
Colacino, JM; Jaskunas, SR; Malcolm, SK | 1 |
Bowsher, RR; Compton, JA; DeSante, KA; Hatcher, BL; Hyslop, DL; Jones, CD; Kirkwood, JA; Mabry, TE; Place, GD | 1 |
Cui, L; Schinazi, RF; Sommadossi, JP; Yoon, S | 1 |
Caldwell, SH; Dickson, RC; Ishitani, MB; McGory, RW; Oliveira, WM; Pruett, TL; Stevenson, WC | 1 |
Caldwell, S; Dickson, R; Gaffey, M; Ishitani, M; Lobo, P; McCullough, C; Pruett, T; Stevenson, W | 1 |
Stone, R | 1 |
Brahams, D | 1 |
Horton, R | 1 |
Colacino, JM; Lewis, W; Meyer, RR; Perrino, FW; Simpson, JF | 1 |
Bowsher, RR; Engelhardt, JA; Richardson, FC | 1 |
Colacino, JM; Jones, CD; Mabry, TE; Staschke, KA | 1 |
Jaenisch, R; Liu, X; Wu, H | 1 |
Macilwain, C | 4 |
Marshall, E | 1 |
Birnbaumer, L; Brabet, P; Bradley, A; Hasty, P; Rudolph, U | 1 |
Blasberg, RG; Desai, R; Gansbacher, B; Stockhammer, G; Tjuvajev, JG; Uehara, H; Watanabe, K | 1 |
Bari, A | 1 |
Josephson, L | 1 |
Lewis, W; Perrino, FW | 1 |
Prince, AM | 1 |
Gordon, M | 1 |
Colacino, JM; Griniuviene, B; Levine, ES; Lewis, W; Perrino, FW; Sommadossi, JP; Tankersley, KO; Watanabe, KA | 1 |
Bishop, JO; Ellison, AR | 1 |
Eriksson, S; Wang, J | 1 |
Colacino, JM | 1 |
Beattie, B; Blasberg, RG; Finn, R; Joshi, R; Kennedy, J; Koutcher, J; Larson, S; Oku, T; Tjuvajev, JG; Watanabe, K | 1 |
Meinert, CL | 1 |
Ahluwalia, GS; Driscoll, JS; Ford, H; Johns, DG | 1 |
Baxter, AJ; Colacino, JM; Huffman, DM; Mabry, TE; Richardson, FC; Richardson, KK; Scheuring, JC; Smith, WC; Staschke, KA | 1 |
Ascenzi, MA; de Courten-Myers, G; Engelman, L; Gerin, JL; Griniuviene, B; Hornbuckle, WE; Levine, ES; Lewis, W; Montione, R; Tankersley, KO; Tennant, BC | 1 |
Gaffey, MJ; Hoofnagle, JH; Kleiner, DE; McKenzie, R; Nichols, L; Sallie, R; Straus, SE; Tsokos, M | 1 |
Colacino, JM; Horn, DM; Neeb, LA; Richardson, FC | 1 |
Dalakas, MC; Leon-Monzon, M; Semino-Mora, C | 1 |
Schmid, R | 1 |
de Man, RA; Honkoop, P; Schalm, SW; Scholte, HR | 1 |
Ascenzi, MA; Baldwin, BH; Bowsher, RR; Colacino, JM; Cote, PJ; Engelhardt, JA; Erb, HN; Gerin, JL; Graham, LA; Hornbuckle, WE; Korba, BE; Lewis, W; Lopez, C; Richardson, FC; Rowland, PH; Tennant, BC; Tochkov, IA; Yeager, AE | 1 |
Vaidyanathan, G; Zalutsky, MR | 1 |
Augensen, F; Avril, N; Beattie, B; Blasberg, R; Daghighian, F; DiResta, G; Finn, R; Humm, J; Joshi, R; Koutcher, J; Larson, SM; Miyagawa, T; Oku, T; Safer, M; Sasajima, T; Tjuvajev, JG; Zweit, J | 1 |
Morton, DM | 1 |
Miller, JP; Mintz, PD | 1 |
Hasty, P; Klein, WH; Vivian, JL | 1 |
Blasberg, RG; Tjuvajev, JG | 1 |
Balatoni, J; Ballon, D; Blasberg, RG; Chen, SH; Finn, R; Guo, ZS; Joshi, A; Joshi, R; Koutcher, J; Tjuvajev, JG; Woo, SL | 1 |
Chiu, JW; Jasin, M; Koller, BH; Moynahan, ME | 1 |
Avril, N; Gansbacher, B; Hantzopoulos, PA; Haubner, R; Schwaiger, M | 1 |
Breakefield, XO; Dubrovin, M; Hewett, J; Jacobs, A; Sadelain, M; Sena-Esteves, M; Slack, M; Tan, CW; Tjuvajev, JG | 1 |
Anton, M; Avril, N; Bengel, FM; Brill, T; Gansbacher, B; Gleiter, E; Haubner, R; Nguyen, N; Schwaiger, M | 1 |
Borrelli, E; Hindelang, C; LeMeur, M; Mathis, C | 1 |
Buchsbaum, DJ; Chaudhuri, TR; Mountz, JM; Rogers, BE; Zinn, KR | 1 |
Akhurst, T; Balatoni, J; Beattie, B; Blasberg, RG; Breakefield, XO; Chiocca, EA; Dubrovin, M; Finn, R; Herrlinger, U; Jacobs, A; Joshi, R; Larson, SM; Pechan, PA; Tjuvajev, JG | 1 |
Fried, MW; Sommadossi, JP | 1 |
Brandau, W; Bräunlich, I; Graf, R; Heiss, WD; Hesselmann, V; Jacobs, A; Lercher, M; Sakaki, T; Voges, J; Wienhard, K | 1 |
Akhurst, T; Balatoni, J; Bennett, JJ; Blasberg, R; Doubrovin, M; Federoff, H; Finn, R; Fong, Y; Hackman, T; Johnson, P; Larson, SM; Malholtra, S; Tjuvajev, J | 1 |
Anton, M; Avril, N; Brust, P; Friedrich, A; Haberkorn, U; Haubner, R; Hauses, M; Johannsen, B; Koufaki, ON; Noll, B; Noll, S; Schackert, G; Schackert, HK; Scheunemann, M | 1 |
Bermudes, D; Blasberg, R; King, I; Luo, X; Tjuvajev, J; Zheng, LM | 1 |
Gossmann, A; Heiss, WD; Jacobs, A; Kaestle, C; Kracht, L; Lercher, M; Reszka, R; Voges, J; Wagner, R; Wienhard, K | 1 |
Akhurst, T; Alauddin, MM; Balatoni, J; Blasberg, RG; Bornmann, W; Cai, S; Conti, PS; Doubrovin, M; Finn, R; Thaler, H; Tjuvajev, JG | 1 |
Avezaat, C; Bakker, W; Bijster, M; Cox, P; de Jong, M; Driesse, M; Havenga, M; Knaus, E; Morin, K; Naimi, E; Nanda, D; Smitt, PS; Vogels, R; Wiebe, L | 1 |
Balatoni, J; Blasberg, RG; Bornmann, W; Doubrovin, M; Doubrovina, E; Finn, R; Gallardo, HF; Heller, G; Ivanova, A; Koehne, G; Larson, SM; May, C; O'Reilly, RJ; Ponomarev, V; Riviere, I; Ruan, S; Sadelain, M; Teruya-Feldstein, J; Tjuvajev, JG; Zanzonico, P | 1 |
Akhurst, T; Balatoni, J; Banerjee, D; Bertino, JR; Blasberg, R; Doubrovin, M; Finn, R; Fong, Y; Gade, T; Gusani, NJ; Koutcher, JA; Larson, S; Mayer-Kuckuk, P; Tjuvajev, JG | 1 |
Anderson, L; Klecker, RW; Mangner, TJ; Shields, AF | 1 |
Borrelli, E; Collin, L; Mathis, C | 1 |
Deng, WP; Fu, YK; Hwang, JJ; Lai, WF; Liu, RS; Wang, HE; Yang, DM; Yang, WK | 1 |
Anton, M; Bengel, FM; Boekstegers, P; Brandau, W; Erhardt, W; Gansbacher, B; Haubner, R; Henke, J; Lehner, T; Nekolla, SG; Reder, S; Richter, T; Schwaiger, M; Simoes, MV | 1 |
Gambhir, SS; Iyer, M; Min, JJ | 1 |
Lai, Y; Tse, CM; Unadkat, JD | 1 |
Ageyeva, L; Balatoni, J; Beresten, T; Blasberg, R; Bornmann, W; Doubrovin, M; Gelovani Tjuvajev, J; Ivanova, A; Ponomarev, V; Serganova, I; Shavrin, A; Tourkova, V; Vider, J | 1 |
Blasberg, R; Burgman, P; Cai, S; Finn, R; Gelovani, J; Li, GC; Ling, CC; O'donoghue, J; Serganova, I; Wen, B; Zanzonico, P | 1 |
Anton, M; Bengel, FM; Erhardt, W; Gambhir, SS; Gansbacher, B; Grote, M; Haubner, R; Lehner, T; Miyagawa, M; Noll, B; Noll, S; Reder, S; Schwaiger, M; Simoes, MV; Städele, C; Wagner, B | 1 |
Anton, M; Bengel, FM; Epple, P; Haubner, R; Lehner, T; Linke, W; Miyagawa, M; Reder, S; Schwaiger, M; Simões, MV; Städele, C | 1 |
Agrawal, N; Bettegowda, C; Cheong, I; Dang, LH; Diaz, L; Dick, J; Foss, CA; Fox, J; Kinzler, KW; Pomper, MG; Vogelstein, B; Wang, Y; Zhou, S | 1 |
Lai, Y; Lee, EW; Unadkat, JD; Zhang, H | 1 |
Blasberg, RG; Doubrovin, M; Doubrovina, E; Finn, R; Gallardo, HF; Koehne, G; Larson, SM; O'Reilly, RJ; Riviere, I; Sadelain, M; Zanzonico, P | 1 |
Deng, WP; Gelovani, JG; Hwang, JJ; Lin, M; Liu, RS; Wang, HE; Wei, HJ; Yu, HM | 1 |
Brown, SM; Dempsey, MF; Hadley, DM; Nicol, A; Owens, J; Papanastassiou, V; Patterson, J; Pimlott, S; Rampling, R; Wyper, D | 1 |
Chen, FD; Chen, JC; Deng, WP; Hsieh, CH; Hwang, JJ; Liu, RS; Wang, HE | 1 |
Ambinder, RF; Chen, J; Chong, JM; Foss, CA; Fox, JJ; Fu, DX; Lemas, V; Pomper, MG; Tanhehco, YC | 1 |
Douglas, KA; Mangner, TJ; Muzik, O; Nimmagadda, S; Shields, AF | 1 |
Agrawal, N; Bettegowda, C; Cheong, I; Conway, J; Diaz, LA; Endres, CJ; Foss, CA; Kinzler, KW; Ladenson, PW; Mont, MA; Nimmagadda, S; Pomper, MG; Seyler, TM; Thornton, K; Ulrich, SD; Uzuner, O; Vogelstein, B; Vogelstein, BN; Zhang, X; Zhou, S | 1 |
Dhanvantari, S; Kovacs, MS; McGirr, R; Morgan, TG; Nguyen, B; Prato, FS; Tai, JH; Wells, RG | 1 |
Dittmar, K; Heiss, WD; Jacob, AJ; Jacobs, AH; Knaus, EE; Li, HF; Moharram, S; Stöckle, M; Wiebe, LI; Winkeler, A | 1 |
Deisenhofer, S; Glatting, G; Kull, T; Morgenroth, A; Neininger, M; Reske, SN; Vogg, AT | 1 |
Chang, WS; Chen, CT; Hsu, CH; Lee, TW; Lin, KM | 1 |
Endres, CJ; Govindarajan, R; LeCluyse, E; Pastor-Anglada, M; Tse, CM; Unadkat, JD; Whittington, D | 1 |
Ambinder, RF; Chen, J; Chong, JM; Foss, CA; Fox, JJ; Fu, DX; Fukayama, M; Hobbs, RF; Kowalski, J; Pomper, MG; Sgouros, G; Tanhehco, Y | 1 |
Chen, Q; Deng, X; He, F; Huang, Y; Li, GC; Ling, CC; Liu, Y; Minami, A; Sun, X; Wen, B; Xing, L; Zanzonico, PB | 1 |
Blankemeyer, E; Chacko, AM; Kung, HF; Lieberman, BP; Qu, W | 1 |
Lan, X; Liu, Y; Wang, R; Yin, X; Zhang, Y | 1 |
Haberkorn, U; Lawhorn-Crews, JM; Mangner, TJ; Nimmagadda, S; Shields, AF | 1 |
Be, NA; Bishai, WR; Davis, SL; Jain, SK; Lamichhane, G; Nimmagadda, S; Pomper, MG | 1 |
Pomper, MG | 1 |
Ahn, BC; Choi, TH; Ha, JH; Kim, IS; Lee, J; Lee, SW; Lee, YJ; Lee, YL; Park, SY | 1 |
An, GI; Cheon, GJ; Choi, CW; Choi, TH; El-Gamal, MI; Hong, SH; Kim, EJ; Kim, KM; Lee, EA; Lee, KC; Lim, SM | 1 |
Anderson, H; Cantorias, M; Lewis, JS; Pillarsetty, N | 1 |
Awasthi, S; Awasthi, V; King, C; Lagisetty, P; Shankar, N; Vilekar, P | 1 |
Cai, H; Conti, PS; Li, Z | 1 |
Alauddin, M; Chan, PC; Chang, WT; Chang, WY; Chen, CL; Chen, FD; Lin, WJ; Liu, RS; Wang, HE; Wu, CY | 1 |
An, GI; Cheon, GJ; Jang, SJ; Kang, JH; Kim, KI; Lee, KC; Lee, TS; Lee, YJ; Lim, S; Lim, SM | 1 |
Cheng, Z; He, Y; Lan, X; Mghanga, FP; Pei, Z; Qin, C; Tian, Y; Wang, P; Yen, TC; Zhang, Y | 1 |
Chun, KS; Kang, JH; Kim, KI; Lee, TS; Lee, YJ; Park, JJ; Park, YS; Son, JJ; Song, IH | 1 |
An, R; Lang, J; Liu, Y; Sun, X; Wu, T; Zhang, B | 1 |
Freeman, AF; Gharib, AM; Hammoud, DA; Holland, SM; Peterson, KL; Pettigrew, RI; Reid, WC | 1 |
Heo, K; Kang, SH; Kim, D; Kim, EO; Kim, H; Kim, IH; Kim, KT; Kim, SK; Kim, YH; Koh, SS; Lee, SJ; Lee, SW; Lee, Y; Moon, JY; Song, MS | 1 |
Glenn, J; Guo, YY; Masek, M; Michie, SA; Nishimura, S; Nishimura, T; Peltz, G; Xu, D; Zhang, H; Zheng, M | 1 |
Cohen, J | 1 |
Bettegowda, C; Cheung, PH; DeCrescenzo, G; Saha, S; Tung, D; Welsch, D | 1 |
Bell, CC; Dankers, AC; Ellis, E; Fredriksson Puigvert, L; Goldring, CE; Hendriks, DF; Ingelman-Sundberg, M; Jacobs, F; Jenkins, RE; Kitteringham, NR; Lauschke, VM; Mkrtchian, S; Moro, SM; Nordling, Å; Park, BK; Renblom, A; Sison-Young, RL; Snoeys, J; Walsh, J | 1 |
Alavi, A; Barnett, TM; Berkowitz, RD; Bettegowda, C; Cho, SY; Conklin, JJ; Gelb, J; McLeroth, P; Mont, MA; Petit, C; Pomper, MG; Saha, S; Siegel, BA; Spaltro, J; Stabin, MG; Zhang, HH; Zhang, XM | 1 |
Amberntsson, S; Andersson, LC; Cairns, J; Chouhan, B; Darnell, M; Ewart, L; Foster, AJ; Hamilton, GA; Jang, KJ; Kodella, K; Lazic, SE; Morgan, P; Petropolis, DB; Regan, SL; Rollison, H; Rubins, JE; Srivastava, A; Williams, D | 1 |
Beckett, AJ; Chadwick, AE; Douglas, O; Jenkins, RE; Jolly, CE; Kamalian, L; Monshouwer, M; Park, BK; Penman, SL; Simic, D; Snoeys, J; Williams, DP | 1 |
Dixon, D; Fallon, JK; Liu, J; Mosedale, M; Nautiyal, M; Qasem, RJ; Smith, PC; Wolf, KK | 1 |
8 review(s) available for arabinofuranosyluracil and fialuridine
Article | Year |
---|---|
Fluorinated pyrimidines: a new change for old drugs.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Arabinofuranosyluracil; Bone Marrow Transplantation; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Pyrimidines; Structure-Activity Relationship | 1991 |
Mitochondrial toxicity of antiviral drugs.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Arabinofuranosyluracil; Didanosine; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Humans; Mitochondria; Zalcitabine; Zidovudine | 1995 |
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine | 1995 |
New developments in antiviral therapy for chronic hepatitis B infection.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine | 1995 |
Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU).
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; DNA, Mitochondrial; Electron Transport Complex IV; Hepatitis B; Hepatitis B virus; Humans; Liver | 1996 |
Mitochondrial injury. Lessons from the fialuridine trial.
Topics: Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B virus; Humans; Liver; Mitochondria; Oxidation-Reduction; Pyruvates; Risk Assessment; Structure-Activity Relationship | 1997 |
Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Gene Expression Regulation, Enzymologic; Genes, Reporter; Genetic Markers; Genetic Therapy; Neoplasms, Experimental; Radiopharmaceuticals; Simplexvirus; Thymidine Kinase; Tomography, Emission-Computed; Transgenes; Tumor Cells, Cultured | 1999 |
Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Combined Modality Therapy; Dideoxynucleosides; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Ribavirin; Vidarabine | 1996 |
5 trial(s) available for arabinofuranosyluracil and fialuridine
Article | Year |
---|---|
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; DNA, Mitochondrial; DNA, Viral; Drugs, Investigational; Female; Hepatitis B; Humans; Jaundice; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases | 1995 |
Deaths in US fialuridine trial.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Survival Rate | 1994 |
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.
Topics: Aged; Antiviral Agents; Arabinofuranosyluracil; Gene Expression Regulation, Viral; Genetic Therapy; Glioblastoma; Herpesvirus 1, Human; Humans; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Thymidine Kinase; Tomography, Emission-Computed; Transduction, Genetic | 2001 |
Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma.
Topics: Arabinofuranosyluracil; Gene Expression; Gene Expression Profiling; Genetic Therapy; Glioma; Humans; Iodine Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Simplexvirus; Thymidine Kinase; Viral Proteins; Virus Replication | 2006 |
[(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection.
Topics: Adult; Arabinofuranosyluracil; Female; Humans; Joint Diseases; Male; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiometry; Safety; Tissue Distribution | 2016 |
126 other study(ies) available for arabinofuranosyluracil and fialuridine
Article | Year |
---|---|
Antiviral activity of FIAU (1-[2'deoxy-2'-fluoro-1-beta-D-arabinofuranosyl]-5-iodo-uridine) on strains of cytomegalovirus sensitive and resistant to ganciclovir.
Topics: Antiviral Agents; Arabinofuranosyluracil; Cytomegalovirus; Drug Resistance, Microbial; Ganciclovir; Humans | 1991 |
Equine herpes virus 1 and pseudorabies virus resistance to 2'-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cytarabine; Drug Resistance, Microbial; Herpesviridae; Herpesvirus 1, Suid; Horses; Nucleoside-Phosphate Kinase; Pseudorabies; Pyrimidine Nucleosides; Substrate Specificity | 1990 |
Transgenic mice with inducible dwarfism.
Topics: Animals; Arabinofuranosyluracil; Body Weight; Dwarfism, Pituitary; Growth Hormone; Immunohistochemistry; Mice; Mice, Transgenic; Pituitary Gland; Prolactin; Thymidine Kinase | 1989 |
Targeting of an inducible toxic phenotype in animal cells.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Blotting, Northern; Blotting, Southern; Cell Line; Cell Line, Transformed; Cell Survival; Densitometry; DNA Replication; Gene Expression Regulation; Mice; Mice, Transgenic; Plasmids; Rats; Simplexvirus; Spleen; Thymidine Kinase; Thymus Gland; Transfection; Uridine | 1988 |
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Topics: Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Idoxuridine; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Vidarabine | 1985 |
Comparative efficacy of three 2'-fluoropyrimidine nucleosides and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (BW B759U) against pseudorabies and equine rhinopneumonitis virus infection in vitro and in laboratory animals.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cricetinae; Cytarabine; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Equid; Herpesvirus 1, Suid; Male; Mice; Pseudorabies; Pyrimidine Nucleosides | 1987 |
A mammalian cell line designed to test the mutagenic activity of anti-herpes nucleosides.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Division; Cell Line; Cricetinae; Cricetulus; Cytarabine; DNA, Viral; Idoxuridine; Mutagenicity Tests; Nucleosides; Simplexvirus; Thymidine Kinase; Transfection; Trifluridine | 1987 |
Effect of acyclovir on the uptake of 131I-labelled 1-(2'fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in herpes infected cells.
Topics: Acyclovir; Animals; Arabinofuranosyluracil; Cells, Cultured; Simplexvirus; Time Factors; Uridine | 1987 |
[Radiosensitization effects of nucleoside analogs].
Topics: Acyclovir; Animals; Antineoplastic Agents; Arabinofuranosyluracil; Cytarabine; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nucleosides; Radiation-Sensitizing Agents; Vidarabine; Whole-Body Irradiation | 1986 |
Selective inhibitory effects of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl) adenine and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil on seal herpesvirus (phocid herpesvirus 1) infection in vitro.
Topics: Adenine; Animals; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Herpesviridae; Organophosphonates; Organophosphorus Compounds; Seals, Earless; Uridine | 1987 |
Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeys.
Topics: Administration, Oral; Animals; Antiviral Agents; Arabinofuranosyluracil; Aspartate Aminotransferases; Chickenpox; Chlorocebus aethiops; Female; Injections, Intravenous; Male; Time Factors; Uridine | 1986 |
Quantitative determination of antiviral nucleoside analog in DNA.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Cytarabine; DNA, Viral; Herpesviridae; Hydrolysis; Nucleosides | 1986 |
Kinetics and substrate specificity of human and canine cytidine deaminase.
Topics: Animals; Arabinofuranosyluracil; Cytarabine; Cytidine; Cytidine Deaminase; Deoxycytidine; Dogs; Humans; Kinetics; Liver; Nucleoside Deaminases; Substrate Specificity | 1986 |
Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
Topics: Acyclovir; Animals; Antibodies, Viral; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; Culture Media; Culture Techniques; Cytarabine; Foscarnet; Mice; Mice, Hairless; Neutralization Tests; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trigeminal Nerve; Vidarabine Phosphate; Virus Activation | 1984 |
Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cytarabine; Female; Foscarnet; Guinea Pigs; Herpes Genitalis; Injections, Intraperitoneal; Male; Phosphonoacetic Acid; Uridine; Virus Replication | 1984 |
Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; DNA Replication; DNA, Viral; Hepatitis B Virus, Duck; Kinetics; Mutagenesis, Site-Directed; Plasmids; Protein Biosynthesis; Rabbits; Reticulocytes; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Substrate Specificity; Templates, Genetic; Transcription, Genetic | 1994 |
Mitochondrial toxicity--new adverse drug effects.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Clinical Trials as Topic; DNA, Mitochondrial; Hepatitis B; Humans; Liver Failure | 1995 |
IOM panel exonerates researchers in FIAU deaths.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drugs, Investigational; Humans; Liver Diseases; Malpractice; National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; United States | 1995 |
Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells.
Topics: Arabinofuranosyluracil; DNA; DNA Repair; Humans; Lactates; Liver; Molecular Structure; Tumor Cells, Cultured | 1994 |
Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture.
Topics: Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; DNA Replication; DNA, Mitochondrial; Hepatoblastoma; Humans; Lactates; Lactic Acid; Liver Neoplasms; T-Lymphocytes; Tumor Cells, Cultured; Zalcitabine | 1994 |
Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers.
Topics: Administration, Oral; Adult; Animals; Antiviral Agents; Arabinofuranosyluracil; Binding, Competitive; Biological Availability; Drug Administration Schedule; Fasting; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Rabbits; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity | 1994 |
Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.
Topics: Adenosine Triphosphate; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Cell Division; Cell Nucleus; Chromatography, High Pressure Liquid; DNA, Mitochondrial; DNA, Neoplasm; Humans; Kinetics; Liver Neoplasms; Microscopy, Electron; Mitochondria; Mitochondria, Liver; Time Factors; Tumor Cells, Cultured | 1995 |
Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; DNA, Viral; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Liver Cirrhosis; Liver Transplantation; Male | 1995 |
Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.
Topics: Antiviral Agents; Arabinofuranosyluracil; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Hepatitis B; Humans; Lactates; Liver Transplantation; Randomized Controlled Trials as Topic | 1995 |
Panel clears NIH in patient deaths.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Humans; National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; National Institutes of Health (U.S.); United States; United States Food and Drug Administration | 1995 |
The context of consent.
Topics: Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Comprehension; Consent Forms; Disclosure; Ethics, Medical; Humans; Informed Consent; Research Subjects; Researcher-Subject Relations; Risk Assessment; Tamoxifen; United States | 1994 |
Mammalian DNA polymerases alpha, beta, gamma, delta, and epsilon incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU Triphosphate.
Topics: Animals; Arabinofuranosyluracil; Binding, Competitive; Deoxyuracil Nucleotides; DNA; DNA-Directed DNA Polymerase; Kinetics; Mammals; Mitochondria; Nucleic Acid Synthesis Inhibitors; Substrate Specificity; Templates, Genetic; Thymine Nucleotides | 1994 |
Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration.
Topics: Administration, Oral; Animals; Antiviral Agents; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; DNA; Dogs; Female; Hydrolysis; Macaca mulatta; Male; Muscles; Radioimmunoassay; Rats; Rats, Inbred F344; Sex Factors; Species Specificity; Time Factors; Tissue Distribution | 1994 |
NIH panel report of 'no flaws' in FIAU trial at variance with FDA report, new probe planned.
Topics: Antiviral Agents; Arabinofuranosyluracil; Cause of Death; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Hepatitis B; Hepatitis, Chronic; Humans; Liver Diseases; National Institutes of Health (U.S.); Scientific Misconduct; United States; United States Food and Drug Administration | 1994 |
The in vitro anti-hepatitis B virus activity of FIAU [1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell.
Topics: Antiviral Agents; Arabinofuranosyluracil; Base Sequence; Hepatitis B virus; Hepatitis B Virus, Duck; Hepatoblastoma; Humans; Molecular Sequence Data; Thymidine; Tumor Cells, Cultured; Virus Replication | 1994 |
Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells.
Topics: Animals; Arabinofuranosyluracil; Cells, Cultured; Collagen; Collagenases; Embryo, Mammalian; Genetic Vectors; Mice; Mutagenesis; Point Mutation; Recombination, Genetic; Selection, Genetic; Stem Cells | 1994 |
Concern grows over reaction to deaths in clinical trials.
Topics: Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Humans; National Institutes of Health (U.S.); United States; United States Food and Drug Administration | 1994 |
US health agencies at odds over trial deaths.
Topics: Arabinofuranosyluracil; Clinical Trials as Topic; Humans; Liver Failure; National Institutes of Health (U.S.); Research Design; United States; United States Food and Drug Administration | 1994 |
Hepatitis study. Drug trial deaths deemed unavoidable.
Topics: Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Federal Government; Government Regulation; Hepatitis B; Humans; National Institutes of Health (U.S.); Pancreatic Diseases; Research Subjects; United States; United States Food and Drug Administration | 1994 |
Trial deaths prompt tighter rules.
Topics: Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Humans; United States; United States Food and Drug Administration | 1993 |
Disruption of the G(i2) alpha locus in embryonic stem cells and mice: a modified hit and run strategy with detection by a PCR dependent on gap repair.
Topics: Animals; Arabinofuranosyluracil; Base Sequence; Chimera; Culture Techniques; DNA Primers; Embryo, Mammalian; Genetic Vectors; GTP-Binding Proteins; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Polymerase Chain Reaction; Recombination, Genetic; Stem Cells; Thymidine Kinase | 1993 |
NIH, FDA seek lessons from hepatitis B drug trial deaths.
Topics: Antiviral Agents; Arabinofuranosyluracil; Hepatitis B; Humans; National Institutes of Health (U.S.); United States; United States Food and Drug Administration | 1993 |
Imaging the expression of transfected genes in vivo.
Topics: Animals; Arabinofuranosyluracil; Autoradiography; Ganciclovir; Gene Expression; Genetic Therapy; Idoxuridine; Rats; RNA, Messenger; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 1995 |
Severe toxicity of fialuridine (FIAU)
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Hepatitis B; Humans; Interferons; Nucleosides | 1996 |
Severe toxicity of fialuridine (FIAU)
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Drug Evaluation, Preclinical; Hepatitis; Humans; Marmota | 1996 |
Severe toxicity of fialuridine (FIAU)
Topics: Antiviral Agents; Arabinofuranosyluracil; DNA Polymerase III; DNA, Mitochondrial; Drug Evaluation, Preclinical; Hepatitis B; Humans; In Vitro Techniques | 1996 |
Severe toxicity of fialuridine (FIAU)
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis; Humans; Marmota; Pan troglodytes | 1996 |
Severe toxicity of fialuridine (FIAU)
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Cytarabine; Drug Approval; Hepatitis B; Humans | 1996 |
Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts.
Topics: Antiviral Agents; Arabinofuranosyluracil; Base Sequence; Binding Sites; Cell Line; DNA Polymerase III; DNA Primers; DNA, Mitochondrial; Humans; Kinetics; Microscopy, Electron; Mitochondria, Liver; Molecular Sequence Data | 1996 |
Initiation of herpes simplex virus thymidine kinase polypeptides.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Base Sequence; Bromodeoxyuridine; Codon; Electrophoresis, Polyacrylamide Gel; Ganciclovir; Gene Expression; Herpesvirus 1, Human; Male; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Peptide Fragments; RNA, Messenger; Testis; Thymidine Kinase; Transfection | 1996 |
Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cattle; Cells, Cultured; Cytosol; Humans; Mitochondria; Phosphorylation; Substrate Specificity; Thymidine Kinase | 1996 |
Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line; Gamma Cameras; Ganciclovir; Gene Transfer Techniques; Genetic Therapy; Glioma; Immunohistochemistry; Iodine Radioisotopes; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Rats; Rats, Nude; Sensitivity and Specificity; Simplexvirus; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon | 1996 |
An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy.
Topics: Adverse Drug Reaction Reporting Systems; Antiviral Agents; Arabinofuranosyluracil; Cidofovir; Cost-Benefit Analysis; Cytosine; Drug Evaluation; Forms and Records Control; Humans; Organophosphonates; Organophosphorus Compounds; Safety Management; United States; United States Food and Drug Administration | 1996 |
Comparison of the DNA incorporation in human MOLT-4 cells of two 2'-beta-fluoronucleosides, 2'-beta-fluoro-2',3'-dideoxyadenosine and fialuridine.
Topics: Antiviral Agents; Arabinofuranosyluracil; Cell Line; Dideoxyadenosine; DNA; Humans | 1996 |
Differential effects of the incorporation of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) on the binding of the transcription factors, AP-1 and TFIID, to their cognate target DNA sequences.
Topics: Antiviral Agents; Arabinofuranosyluracil; Binding, Competitive; Deoxyribonuclease BamHI; Deoxyribonucleases, Type II Site-Specific; DNA; Electrophoresis, Polyacrylamide Gel; HeLa Cells; Humans; Protein Binding; Transcription Factor AP-1; Transcription Factor TFIID; Transcription Factors | 1996 |
Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax).
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; DNA Damage; DNA, Mitochondrial; Heart; Hepatitis B; Hepatitis B Virus, Woodchuck; Kidney; Lipids; Liver; Marmota; Mitochondria; Mitochondria, Muscle; Muscle, Skeletal; Myocardium | 1997 |
Histopathologic changes associated with fialuridine hepatotoxicity.
Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Chronic Disease; Clinical Trials, Phase II as Topic; Female; Hepatitis B; Humans; Liver; Male; Middle Aged; Randomized Controlled Trials as Topic | 1997 |
Fialuridine is phosphorylated and inhibits DNA synthesis in isolated rat hepatic mitochondria.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; DNA Replication; Mitochondria, Liver; Phosphorylation; Rats | 1997 |
Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro.
Topics: Antibodies, Monoclonal; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Humans; Microscopy, Electron; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle, Skeletal; Neural Cell Adhesion Molecules; Organelles | 1997 |
Fialuridine toxicity.
Topics: Antiviral Agents; Arabinofuranosyluracil; Humans; Liver | 1997 |
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
Topics: Animals; Anorexia; Antiviral Agents; Arabinofuranosyluracil; Carrier State; DNA, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Liver; Marmota; Muscles; Sleep Stages; Time Factors; Virus Replication | 1998 |
Preparation of 5-[131I]iodo- and 5-[211At]astato-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil by a halodestannylation reaction.
Topics: Animals; Arabinofuranosyluracil; Cell Line; DNA; Drug Stability; Humans; Indicators and Reagents; Iodine Radioisotopes; Isotope Labeling; Mice; Radiopharmaceuticals; Tin; Tissue Distribution; Tumor Cells, Cultured | 1998 |
Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Carcinoma 256, Walker; Female; Ganciclovir; Gene Transfer Techniques; Glioma; Herpesvirus 1, Human; Iodine Radioisotopes; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Rats; Rats, Nude; Sensitivity and Specificity; Thymidine Kinase; Tomography, Emission-Computed | 1998 |
Importance of species selection in drug toxicity testing.
Topics: Animals; Arabinofuranosyluracil; Humans; Pharmacokinetics; Species Specificity; Toxicology | 1998 |
Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
Topics: Acidosis, Lactic; Anticoagulants; Antiviral Agents; Arabinofuranosyluracil; Calcium; Citrates; Citric Acid; Hepatitis B; Hepatorenal Syndrome; Humans; Liver Failure; Liver Transplantation; Male; Middle Aged; Plasma Exchange; Predictive Value of Tests; Spectrophotometry, Atomic | 1994 |
Temporal, spatial and tissue-specific expression of a myogenin-lacZ transgene targeted to the Hprt locus in mice.
Topics: Animals; Arabinofuranosyluracil; Gene Expression Regulation, Developmental; Gene Targeting; Herpesvirus 1, Human; Histocytochemistry; Hypoxanthine Phosphoribosyltransferase; Lac Operon; Mice; Mice, Transgenic; Muscle Proteins; Muscle, Skeletal; Myogenin; Promoter Regions, Genetic; Stem Cells; Thymidine Kinase; X Chromosome | 1999 |
Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
Topics: Adenoviridae; Animals; Arabinofuranosyluracil; Autoradiography; Colonic Neoplasms; Ganciclovir; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Iodine Radioisotopes; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Simplexvirus; Thymidine Kinase; Tumor Cells, Cultured | 1999 |
Brca1 controls homology-directed DNA repair.
Topics: Animals; Arabinofuranosyluracil; BRCA1 Protein; Cell Line; Chromosomes; DNA Damage; DNA Repair; DNA-Binding Proteins; Gene Targeting; Mice; Mice, Knockout; Mutation; Proto-Oncogene Proteins; Rad51 Recombinase; Recombination, Genetic; Retinoblastoma Protein; Stem Cells; Thymidine Kinase; Transfection | 1999 |
In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.
Topics: Animals; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Fibrosarcoma; Gene Expression; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Herpesvirus 1, Human; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Radionuclide Imaging; Thymidine Kinase; Tissue Distribution; Transduction, Genetic | 2000 |
Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Blotting, Western; Cell Separation; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Flow Cytometry; Ganciclovir; Genetic Therapy; Green Fluorescent Proteins; Herpesvirus 1, Human; Luminescent Proteins; Microscopy, Fluorescence; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; Retroviridae; Thymidine Kinase; Transduction, Genetic; Transgenes; Tumor Cells, Cultured | 1999 |
Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging.
Topics: Adenoviridae; Animals; Arabinofuranosyluracil; Autoradiography; Carbon Radioisotopes; Cell Line; Gene Expression; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Injections, Intravenous; Iodine Radioisotopes; Myocardium; Radiopharmaceuticals; Rats; Rats, Wistar; Simplexvirus; Thymidine Kinase; Time Factors | 2000 |
A transgenic mouse model for inducible and reversible dysmyelination.
Topics: Animals; Antigens, Differentiation; Arabinofuranosyluracil; Blotting, Northern; Brain; Demyelinating Diseases; Disease Models, Animal; Female; Glial Fibrillary Acidic Protein; Gliosis; Herpesvirus 1, Human; In Situ Hybridization; Male; Mice; Mice, Transgenic; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Optic Nerve; Promoter Regions, Genetic; Recombinant Fusion Proteins; RNA, Messenger; Sciatic Nerve; Thymidine Kinase | 2000 |
Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging.
Topics: Adenoviridae; Arabinofuranosyluracil; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line; Gamma Cameras; Gamma Rays; Genetic Vectors; Herpesviridae; Humans; Iodine Radioisotopes; Kidney; Lung Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Technetium; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 2001 |
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Topics: Animals; Arabinofuranosyluracil; Autoradiography; Chlorocebus aethiops; Gene Expression Regulation, Viral; Genetic Vectors; Glioma; Gliosarcoma; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Lac Operon; Mice; Mice, Nude; Mutation; Rats; Thymidine Kinase; Tomography, Emission-Computed; Transgenes; Vero Cells; Virus Replication | 2001 |
Quantitative kinetics of [124I]FIAU in cat and man.
Topics: Animals; Arabinofuranosyluracil; Blood-Brain Barrier; Brain; Brain Neoplasms; Cats; Gene Expression; Genetic Therapy; Glioblastoma; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thymidine Kinase; Tissue Distribution; Tomography, Emission-Computed; Transduction, Genetic | 2001 |
Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer.
Topics: Antiviral Agents; Arabinofuranosyluracil; Autoradiography; Biological Therapy; Herpesvirus 1, Human; Humans; Neoplasms; Promoter Regions, Genetic; Thymidine Kinase; Tomography, Emission-Computed; Tumor Cells, Cultured; Virus Replication | 2001 |
Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line; Cells, Cultured; Enzyme Inhibitors; Ganciclovir; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Viral; Genetic Vectors; Herpesvirus 1, Human; Mice; Mice, Inbred BALB C; Radiopharmaceuticals; Thymidine Kinase; Tissue Distribution; Transfection; Transgenes | 2001 |
Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging.
Topics: Animals; Arabinofuranosyluracil; Genetic Markers; Genetic Vectors; Herpesvirus 1, Human; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms; Protein-Tyrosine Kinases; Salmonella; Tissue Distribution; Tumor Cells, Cultured | 2001 |
Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.
Topics: Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Fluorodeoxyglucose F18; Gene Expression; Herpesvirus 1, Human; Iodine Radioisotopes; Nucleosides; Radiopharmaceuticals; Rats; Rats, Nude; Thymidine Kinase; Tomography, Emission-Computed | 2002 |
Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU.
Topics: Adenoviridae; Animals; Arabinofuranosyluracil; Biomarkers, Tumor; Female; Gene Expression; Gene Expression Regulation, Viral; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Glioma; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Mice; Nucleosides; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution; Transduction, Genetic; Transfection; Tumor Cells, Cultured | 2002 |
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.
Topics: Animals; Apoptosis; Arabinofuranosyluracil; Biomarkers, Tumor; Cell Line; Cell Movement; Cell Survival; Herpesvirus 4, Human; Humans; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, SCID; Neoplasm Transplantation; Radiopharmaceuticals; Sensitivity and Specificity; Simplexvirus; T-Lymphocytes; Thymidine Kinase; Tissue Distribution; Tomography, Emission-Computed; Transduction, Genetic | 2003 |
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats.
Topics: Animals; Animals, Genetically Modified; Arabinofuranosyluracil; Cell Line, Tumor; Colorectal Neoplasms; Feasibility Studies; Folic Acid Antagonists; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Nude; Recombinant Fusion Proteins; Tetrahydrofolate Dehydrogenase; Thymidine Kinase; Tissue Distribution; Transplantation, Heterologous; Viral Proteins; Whole-Body Counting | 2003 |
Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU.
Topics: Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Fluorine Radioisotopes | 2003 |
Oligodendrocyte ablation impairs cerebellum development.
Topics: Animals; Animals, Newborn; Arabinofuranosyluracil; Astrocytes; Cell Movement; Cerebellum; In Situ Hybridization; Interneurons; Mice; Mice, Transgenic; Oligodendroglia; Phenotype; Purkinje Cells; Time Factors | 2003 |
Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir.
Topics: Animals; Arabinofuranosyluracil; Cell Line, Tumor; Female; Ganciclovir; Genetic Therapy; Iodine Radioisotopes; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Thymidine Kinase; Tissue Distribution; Viral Proteins | 2004 |
Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer.
Topics: Animals; Arabinofuranosyluracil; Blood Flow Velocity; Coronary Circulation; Feasibility Studies; Gene Expression; Gene Transfer Techniques; Genes, Reporter; Heart; Iodine Radioisotopes; Models, Animal; Myocardium; Swine; Thymidine Kinase; Tomography, Emission-Computed; Transgenes | 2003 |
Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection.
Topics: Adenoviridae Infections; Animals; Arabinofuranosyluracil; Cell Line, Tumor; Genes, Reporter; Glioma; Guanine; Intracellular Signaling Peptides and Proteins; Male; Metabolic Clearance Rate; Mice; Organ Specificity; Proteins; Radiopharmaceuticals; Rats; Tissue Distribution; Tomography, Emission-Computed; Transfection | 2003 |
Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Biological Transport, Active; Cell Line; Dogs; Equilibrative Nucleoside Transporter 1; Humans; In Vitro Techniques; Intracellular Membranes; Membrane Transport Proteins; Mitochondria, Liver; Recombinant Fusion Proteins; Subcellular Fractions | 2004 |
A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging.
Topics: Animals; Arabinofuranosyluracil; Cell Line, Tumor; Gene Transfer Techniques; Genes, Reporter; Glioma; Green Fluorescent Proteins; Humans; Iodine Radioisotopes; Luminescent Proteins; Mice; Mice, Nude; Microscopy, Fluorescence; Protein Engineering; Radionuclide Imaging; Recombinant Fusion Proteins; Thymidine Kinase; Viral Proteins; Whole-Body Counting | 2004 |
A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Feasibility Studies; Fluorine Radioisotopes; Gene Expression Profiling; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Misonidazole; Nuclear Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Thymidine Kinase; Transcription Factors; Viral Proteins | 2004 |
PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene.
Topics: Animals; Arabinofuranosyluracil; Gene Expression Profiling; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Guanine; Heart; Iodine Radioisotopes; Male; Myocardium; Positron-Emission Tomography; Rats; Rats, Wistar; Species Specificity; Swine; Thymidine Kinase; Tissue Distribution; Transgenes; Viral Proteins | 2004 |
Myocardial kinetics of reporter probe 124I-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene.
Topics: Adenoviridae; Animals; Arabinofuranosyluracil; Computer Simulation; Feasibility Studies; Gene Expression Profiling; Gene Transfer Techniques; Genes, Reporter; Heart; Iodine Radioisotopes; Kinetics; Male; Metabolic Clearance Rate; Models, Cardiovascular; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Recombinant Proteins; Thymidine Kinase; Transfection; Viral Proteins | 2005 |
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.
Topics: Amino Acid Sequence; Animals; Arabinofuranosyluracil; Cell Line; Escherichia coli; Escherichia coli Infections; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Radionuclide Imaging; Thymidine Kinase | 2005 |
Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine.
Topics: Amino Acid Sequence; Animals; Arabinofuranosyluracil; Biological Transport; Cell Line; Dogs; Equilibrative Nucleoside Transporter 1; Mice; Mitochondria; Molecular Sequence Data; Mutation; Protein Structure, Tertiary; Rats; Species Specificity | 2006 |
[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity.
Topics: Animals; Arabinofuranosyluracil; Cytotoxicity, Immunologic; Dose-Response Relationship, Radiation; Epstein-Barr Virus Infections; Hematologic Neoplasms; Humans; Immunotherapy, Adoptive; In Vitro Techniques; Iodine Radioisotopes; Mice; Mice, SCID; Radionuclide Imaging; Radiopharmaceuticals; T-Lymphocytes; Transduction, Genetic | 2006 |
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Female; Floxuridine; Fluorodeoxyglucose F18; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Mice; Neoplasms; Prodrugs; Thymidine Kinase; Tyrosine | 2006 |
In vitro evaluation of herpes simplex virus type 1 thymidine kinase reporter system in dynamic studies of transcriptional gene regulation.
Topics: Arabinofuranosyluracil; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genes, Reporter; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Thymidine Kinase; Transcription Factors; Transcription, Genetic; Viral Proteins | 2006 |
Virus-associated tumor imaging by induction of viral gene expression.
Topics: Animals; Antineoplastic Agents; Arabinofuranosyluracil; Boronic Acids; Bortezomib; Burkitt Lymphoma; Diagnostic Imaging; Gene Expression; Gene Transfer Techniques; Genes, Viral; Herpesvirus 4, Human; Humans; Immunoblotting; Mice; Neoplasms, Experimental; Oncogenic Viruses; Pyrazines; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Thymidine Kinase | 2007 |
Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogs.
Topics: Animals; Arabinofuranosyluracil; DNA; Dogs; Fluorine Radioisotopes; Gene Expression Regulation; Genes, Reporter; Genetic Therapy; Kinetics; Liver; Positron-Emission Tomography; Radiometry; Simplexvirus; Thymidine Kinase; Tissue Distribution | 2007 |
Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT.
Topics: Arabinofuranosyluracil; Bacteria; Bacterial Infections; Bone and Bones; Case-Control Studies; Diagnostic Imaging; Humans; Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Substrate Specificity; Thymidine Kinase; Tomography, X-Ray Computed | 2007 |
Imaging of gene expression in live pancreatic islet cell lines using dual-isotope SPECT.
Topics: Animals; Arabinofuranosyluracil; Cell Line; Genes, Reporter; Glucagon-Secreting Cells; Green Fluorescent Proteins; Indium Radioisotopes; Insulin-Secreting Cells; Iodine Radioisotopes; Mice; Radiopharmaceuticals; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tropolone | 2008 |
In vivo evaluation of the uptake of [(123)I]FIAU, [(123)I]IVFRU and [(123)I]IVFAU by normal mouse brain: potential for noninvasive assessment of HSV-1 thymidine kinase gene expression in gliomas.
Topics: Animals; Arabinofuranosyluracil; Blood-Brain Barrier; Brain; Brain Neoplasms; Floxuridine; Gene Expression; Glioma; Herpesvirus 1, Human; Iodine Radioisotopes; Male; Mice; Mice, Nude; Thymidine Kinase; Tissue Distribution; Uridine | 2008 |
Biodistribution, cellular uptake and DNA-incorporation of the 2'-fluoro stabilized 5-iodo-2'-deoxyuridine analog 5-iodo-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU).
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Chemistry, Pharmaceutical; DNA; HL-60 Cells; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Phosphorylation; Thymidine Kinase; Thymidine Phosphorylase; Tissue Distribution | 2008 |
Human breast tumor cells express multimodal imaging reporter genes.
Topics: Animals; Arabinofuranosyluracil; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Ganciclovir; Genes, Reporter; Genetic Vectors; Glucose; Humans; Mice; Mice, Inbred ICR; Mice, Nude; Positron-Emission Tomography; Substrate Specificity; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2008 |
Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
Topics: Adult; Aged; Arabinofuranosyluracil; Bile; Cell Culture Techniques; Cell Membrane; Cells, Cultured; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Female; Formycins; Guanosine; Hepatocytes; Humans; Male; Membrane Transport Proteins; Middle Aged; Nucleosides; Ribavirin; RNA, Messenger; Thymidine | 2008 |
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
Topics: Animals; Antineoplastic Agents; Arabinofuranosyluracil; Boronic Acids; Bortezomib; Burkitt Lymphoma; Cell Line, Tumor; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Iodine Radioisotopes; Male; Mice; Mice, SCID; Pyrazines; Radiopharmaceuticals; Sarcoma, Kaposi; Stomach Neoplasms; Thymidine Kinase | 2008 |
Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.
Topics: Animals; Antigens, Neoplasm; Arabinofuranosyluracil; Autoradiography; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Etanidazole; Female; Gene Expression; Green Fluorescent Proteins; Herpesvirus 1, Human; HT29 Cells; Humans; Hydrocarbons, Fluorinated; Immunohistochemistry; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Positron-Emission Tomography; Thymidine Kinase; Tissue Distribution; Transplantation, Heterologous | 2008 |
5-[18F]Fluoroalkyl pyrimidine nucleosides: probes for positron emission tomography imaging of herpes simplex virus type 1 thymidine kinase gene expression.
Topics: Animals; Arabinofuranosyluracil; Cell Line, Tumor; Fluorine Radioisotopes; Gene Expression; Genes, Reporter; Glioma; Herpesvirus 1, Human; Male; Mice; Mice, Nude; Positron-Emission Tomography; Pyrimidine Nucleosides; Rats; Reproducibility of Results; Sensitivity and Specificity; Thymidine Kinase; Time Factors; Tissue Distribution; Transplantation, Heterologous | 2009 |
Comparative study of cellular kinetics of reporter probe [(131)I]FIAU in neonatal cardiac myocytes after transfer of HSV1-tk reporter gene with two vectors.
Topics: Adenoviridae; Animals; Animals, Newborn; Arabinofuranosyluracil; Cells, Cultured; Gene Transfer Techniques; Genetic Therapy; Herpesvirus 1, Human; Immunohistochemistry; Iodine Radioisotopes; Isotope Labeling; Liposomes; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Thymidine Kinase | 2009 |
Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil).
Topics: Animals; Arabinofuranosyluracil; Biological Transport; Cell Line, Tumor; Fluorine Radioisotopes; Gene Expression Regulation, Enzymologic; Humans; Male; Mice; Molecular Imaging; Rats; Simplexvirus; Substrate Specificity; Thymidine Kinase | 2009 |
Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals.
Topics: Animals; Arabinofuranosyluracil; Chromosomes, Bacterial; Female; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Promoter Regions, Genetic; Thymidine Kinase | 2009 |
Letter to the editor.
Topics: Arabinofuranosyluracil; Bacterial Infections; Clinical Trials as Topic; Diagnostic Imaging; Humans; Liver Failure | 2009 |
Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model.
Topics: Animals; Arabinofuranosyluracil; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; Male; Mice; Mice, Inbred BALB C; RNA, Small Interfering; Thymidine Kinase; Xenograft Model Antitumor Assays | 2010 |
Effects of structural differences between radioiodine-labeled 1-(2'-fluoro-2'-deoxy-D-arabinofuranosyl)-5-iodouracil (FIAU) and 1-(2'-fluoro-2'-deoxy-d-ribofuranosyl)-5-iodouracil (FIRU) on HSV1-TK reporter gene imaging.
Topics: Animals; Arabinofuranosyluracil; Floxuridine; Genes, Reporter; Herpesvirus 1, Human; Iodine Radioisotopes; Mice; Protein-Tyrosine Kinases; Viral Proteins | 2010 |
Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU).
Topics: Arabinofuranosyluracil; Catalysis; Fluorine Radioisotopes; Kinetics; Mesylates; Trimethylsilyl Compounds | 2010 |
In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.
Topics: Administration, Intranasal; Animals; Arabinofuranosyluracil; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Shape; Cells, Cultured; Coccidioides; Cytokines; Dendritic Cells; DNA, Complementary; Epitopes; Fungal Vaccines; Immunization; Immunologic Memory; Immunophenotyping; Lymphocyte Activation; Mice; Models, Animal; Molecular Imaging; Plasmids; Thymidine Kinase; Tissue Distribution; Transfection; Transgenes | 2010 |
The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy.
Topics: Arabinofuranosyluracil; Bromouracil; Fluorouracil; Radiochemistry; Reference Standards | 2011 |
Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging.
Topics: Animals; Arabinofuranosyluracil; Cell Line, Tumor; Cytarabine; Female; Fluorine Radioisotopes; Herpesvirus 1, Human; Mice; Positron-Emission Tomography; Sarcoma; Thymidine Kinase; Transfection | 2011 |
Imaging of a localized bacterial infection with endogenous thymidine kinase using radioisotope-labeled nucleosides.
Topics: Animals; Arabinofuranosyluracil; Bacterial Infections; Dideoxynucleosides; Focal Infection; Gene Expression; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Salmonella typhimurium; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon | 2012 |
A multimodality reporter gene for monitoring transplanted stem cells.
Topics: Adenoviridae; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow Cells; Genes, Reporter; Green Fluorescent Proteins; Herpesvirus 1, Human; Luciferases, Firefly; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Molecular Imaging; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Thymidine Kinase; Transfection | 2012 |
Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase.
Topics: Animals; Arabinofuranosyluracil; Cell Tracking; Copper Radioisotopes; Female; Gene Transfer Techniques; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luciferases, Firefly; Mice; Mice, Inbred BALB C; Mice, Nude; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones; Thymidine Kinase; Transplantation, Heterologous | 2012 |
Monitoring bone marrow stem cells with a reporter gene system in experimental middle cerebral artery occlusion rat models.
Topics: Animals; Arabinofuranosyluracil; Autoradiography; Behavior, Animal; Bone Marrow Cells; Disease Models, Animal; Feasibility Studies; Genes, Reporter; Herpesvirus 1, Human; Infarction, Middle Cerebral Artery; Isotope Labeling; Male; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Stem Cells; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon | 2013 |
The use of 14C-FIAU to predict bacterial thymidine kinase presence: implications for radiolabeled FIAU bacterial imaging.
Topics: Arabinofuranosyluracil; Bacteria; Biological Transport; Carbon Radioisotopes; Granulomatous Disease, Chronic; Humans; Isotope Labeling; Job Syndrome; Molecular Imaging; Positron-Emission Tomography; Thymidine Kinase | 2013 |
Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model.
Topics: Adenocarcinoma; Adenoviridae; Animals; Arabinofuranosyluracil; Cell Line, Tumor; Female; Genetic Therapy; Humans; Intercellular Signaling Peptides and Proteins; Iodine Radioisotopes; Lectins; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Random Allocation; RNA; RNA, Catalytic; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon; Transgenes; Xenograft Model Antitumor Assays | 2014 |
Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Chimera; Drug Evaluation, Preclinical; Female; Humans; Liver; Liver Failure, Acute; Male; Mice; Models, Animal; Toxicity Tests | 2014 |
Toxicology. 'Humanized' mouse detects deadly drug side effects.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Chimera; Hepatocytes; Humans; Liver; Liver Transplantation; Mice; Mice, Transgenic; Models, Animal; Toxicity Tests | 2014 |
Evaluation of 1-(2-deoxy-2-fluoro-1-D-arabinofuranosyl)-5-iodouracil (FIAU) as an ex vivo bacterial detection agent.
Topics: Arabinofuranosyluracil; Bacteria; Bacterial Infections; Bacteriological Techniques; Diagnostic Errors; Humans; Point-of-Care Systems; Radiometry; Urinary Tract Infections; Urine | 2014 |
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.
Topics: Arabinofuranosyluracil; Cells, Cultured; Chemical and Drug Induced Liver Injury; Hepatocytes; Humans; Models, Biological; Proof of Concept Study; Proteome; Spheroids, Cellular | 2016 |
Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid.
Topics: Acetaminophen; Arabinofuranosyluracil; Biomarkers; Cell Culture Techniques; Cell Survival; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Glutathione Transferase; Hepatocytes; Humans; Liver; Models, Biological; Spheroids, Cellular | 2019 |
The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine.
Topics: Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; DNA Replication; DNA, Mitochondrial; Dose-Response Relationship, Drug; Hepatocytes; Humans; Mitochondria | 2020 |
Characterization of primary mouse hepatocyte spheroids as a model system to support investigations of drug-induced liver injury.
Topics: Acetaminophen; Adenosine Triphosphate; Albumins; Animals; Arabinofuranosyluracil; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Female; Hepatocytes; Male; Mice, Inbred C57BL; Models, Biological; Phenylacetates; Proteomics; Spheroids, Cellular; Sulfonamides; Tolvaptan; Transcriptome | 2021 |